This is concordant with PGE2 being the major prostanoid in tumor microenvironments [6, 48] and fits previous observations in ApcMin transgenic mice, where deletion of PTGER1, PTGER2, and PTGER4 inhibits the development of CRC [49–51]. The gene discussed is PTGER1; the disease is colorectal carcinoma.